Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer

被引：0
|
作者：
Jessie R. Nedrow
Joseph D. Latoche
Kathryn E. Day
Jalpa Modi
Tanushree Ganguly
Dexing Zeng
Brenda F. Kurland
Clifford E. Berkman
Carolyn J. Anderson
机构：
[1] University of Pittsburgh,Department of Radiology
[2] University of Pittsburgh,Department of Pharmacology and Chemical Biology
[3] University of Pittsburgh,Department of Bioengineering
[4] University of Pittsburgh,Department of Biostatistics
[5] Washington State University,Department of Chemistry
来源：
Molecular Imaging and Biology | 2016年 / 18卷
关键词：
PSMA; PET; Copper-64; Phosphoramidate; Irreversible inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：402 / 410
页数：8
相关论文
共 47 条
  • [31] Radiosynthesis and preclinical evaluation of a new Al18F-labeled Urea-based PSMA inhibitor for PET imaging of prostate cancer
    Cleeren, Frederik
    Lecina, Joan
    Ahamed, Muneer
    Holvoet, Bryan
    Deroose, Christophe
    Goffin, Karolien
    Verbruggen, Alfons
    Bormans, Guy
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [32] Assessment of in vivo internalization by microPET imaging of prostate specific membrane antigen (PSMA)-expressing xenografts using 64Cu vs 124I radiolabeled minibodies
    Olafsen, Tove
    Ho, David
    Lipman, Arye
    Bander, Neil
    Reiter, Robert
    Behrenbruch, Christian
    Wu, Anna
    Lepin, Eric
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [33] Preclinical evaluation of a 68Ga- and 64Cu-labeled urea-based inhibitor of the prostate specific membrane antigen (PSMA). A promising diagnostic radiopharmaceutical for prostate cancer imaging.
    Gourni, Eleni
    Goncalves, Victor
    Denat, Franck
    Meyer, Phillip
    Maecke, Helmut R.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S59 - S59
  • [34] Detection Rate of 64Cu-SAR-Bombesin-PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal 68Ga-PSMA-11-PET/CT
    Li, S.
    Nguyen, A.
    Counter, W.
    John, N.
    De Leon, J.
    Hruby, G.
    Joshua, A. M.
    Stricker, P.
    Wong, K.
    Liu, V.
    Lengyelova, E.
    Agrawal, S.
    Emmett, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S181 - S181
  • [35] PRELIMINARY INVESTIGATION OF A GALLIUM-68, COPPER-64 AND LUTETIUM-177 LABELED PSMA TARGETING LIGAND FOR IMAGING AND RADIONUCLIDE THERAPY OF PROSTATE CANCER
    Weineisen, M.
    Roselt, P.
    Cullinane, C.
    O'Keefe, G.
    Rigopoulos, A.
    Hicks, R.
    Wester, H. J.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 4 - 5
  • [36] The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy
    Talaat Ahmed Abd El Hameed Hassan
    Mohammed Samy Elazab
    Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [37] The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy
    Hassan, Talaat Ahmed Abd El Hameed
    Elazab, Mohammed Samy
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2020, 51 (01):
  • [38] Comparison of PET/CT in Subjects with Confirmed Prostate Cancer Using 64Cu SAR-bisPSMA and 68Ga PSMA-11
    Lengyelova, Eva
    Wong, Veronica
    Lenzo, Nat
    Parker, Michelle
    Emmett, Louise
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [39] 64Cu-PSMA-BCH-ZL PET imaging of prostate cancer patients and it's potential application in peptide receptor-radionuclide guided surgery
    Zhu, Hua
    Liu, Teli
    Liu, Chen
    Li, Nan
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [40] Tumor models for PET-imaging of prostate and breast cancer targeting prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPr)
    Liolios, C.
    Roscher, M.
    Patsis, C.
    Bauder-Wuest, U.
    Eder, M.
    Kopka, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S238 - S239
12345